Publications
The Cancer Letter
Weekly (46x
per year), $375/year or $36/month. This award-winning newsletter provides
the latest on cancer research funding, legislation, policy issues,
drug development, and people in the news. Includes Business
& Regulatory Report, a monthly summary of pharma and biotech industry news. More information
The Cancer Letter's Business & Regulatory Report
-
This newsletter was discontinued in October 2009, but back issues may be viewed in the "BRR Archive" at left by subscribers to The Cancer Letter. Important oncology business news is now covered solely within The Cancer Letter. Please see our Cancer News feed at left for daily news items.
The Clinical Cancer Letter
Monthly
(12x per year), $125/year or $12/month. To
keep up with developments in cancer treatment and
clinical trials in the U.S. and worldwide, turn to
this reliable monthly resource. Written for the practicing oncologist, oncology nurse, and cancer patient advocate. More information